HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

A screenshot from a video demonstrating how to use the HeartBeam ECG device. HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

SAN JOSE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning ...

This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership ...

Wi-Fi signals bounce off humans in predictable patterns and can detect respiration and pulse, creating an invisible, ...

ADInstruments Lt educational platform provides pre designed laboratory exercises that incorporate physiological data acquisition, allowing students to perform ECG recordings while learning proper ...

Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™ ...

Ashley has received royalties or licences from Personalis, Svexa, Swift Bio, Deepcell, and Saturnus Bio; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or ...

Bradyarrhythmia is a common and potentially serious cause of syncope, often difficult to detect due to its intermittent nature. Traditional ECG monitoring methods either provide low diagnostic ...

Abstract: Objective: In this paper we develop and evaluate ECG-SMART-NET for occlusion myocardial infarction (OMI) identification. OMI is a severe form of heart attack characterized by complete ...

WaveformNet is a deep learning project for classifying electrocardiogram (ECG) signals into multiple arrhythmia types using convolutional neural networks. It features two separately trained models: a ...